Reducing Stress PERKs up Anti-tumor Immunity

Area of Science:

• Immunology
• Cancer Biology
• Cellular Stress Response

Background:

• Myeloid-derived suppressor cells (MDSCs) are key regulators of the tumor microenvironment, often promoting tumor progression and immune evasion.
• The unfolded protein response (UPR) is a cellular stress pathway that can be activated in cancer cells and immune cells.
• Oxidative damage and mitochondrial dysfunction are common features in tumors, influencing immune cell function.

Purpose of the Study:

• To investigate the role of the UPR sensor PERK in regulating MDSC function.
• To elucidate the molecular mechanisms by which PERK influences MDSC-mediated immunosuppression.
• To determine the impact of PERK signaling on oxidative stress and immune sensing within the tumor microenvironment.

Main Methods:

• Utilized mouse models of cancer.
• Employed genetic manipulation to study PERK and NRF2 pathways in MDSCs.
• Assessed MDSC suppressive function in vitro and in vivo.
• Analyzed oxidative damage, mitochondrial DNA release, and type I interferon production.

Main Results:

• PERK signaling in MDSCs enhances their immunosuppressive capacity.
• The transcription factor NRF2 is a critical mediator of PERK's effects on MDSCs.
• PERK-NRF2 axis prevents MDSC oxidative damage and suppresses STING-dependent type I interferon production.
• Inhibition of PERK signaling reduced MDSC function and promoted anti-tumor immunity.

Conclusions:

• PERK-mediated signaling is a crucial pathway for MDSC-driven immunosuppression in cancer.
• Targeting the PERK-NRF2 axis in MDSCs represents a potential therapeutic strategy to enhance anti-tumor immunity.
• Understanding these mechanisms provides insights into tumor immune evasion and potential vulnerabilities.